About Index Trending news
Analyze
Pricing
Jounce Therapeutics

Jounce Therapeutics

Work at Jounce Therapeutics? Add yourself to this profile

Jounce Therapeutics

Jounce Therapeutics is developing cancer immune-therapies to harness the immunesystem to attack cancerous cells and tumors.

Elsewhere

Alexa global traffic share

27 Jan 2017
$102,000,000
IPO
Added by

Jounce Gets $102M As Biotech IPOs Gain Steam in ’17

Xconomy
23 Apr 2015
$56,000,000
Venture capital (Series B)
Redmile Group, Foresite Capital, Wellington Management, +5
Added by

The Daily Startup: Jounce Therapeutics Raises $56M as Immunotherapy Stays Hot

VentureWire